Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$609K Buy
14,278
+1,088
+8% +$48.6K 0.11% 160
2026
Q1
$635K Buy
13,190
+2,886
+28% +$135K 0.13% 154
2025
Q4
$499K Buy
10,304
+527
+5% +$26.1K 0.11% 163
2025
Q3
$461K Buy
9,777
+295
+3% +$14.2K 0.1% 163
2025
Q2
$458K Buy
9,482
+149
+2% +$7.61K 0.11% 149
2025
Q1
$518K Buy
9,333
+1,056
+13% +$57.2K 0.14% 135
2024
Q4
$399K Buy
8,277
+520
+7% +$26.4K 0.11% 158
2024
Q3
$447K Sell
7,757
-297
-4% -$16K 0.12% 147
2024
Q2
$391K Buy
8,054
+1,518
+23% +$73.2K 0.12% 144
2024
Q1
$318K Buy
6,536
+1,633
+33% +$79.7K 0.1% 159
2023
Q4
$244K Sell
4,903
-764
-13% -$37.4K 0.09% 178
2023
Q3
$304K Sell
5,667
-5
-0.1% -$267 0.12% 142
2023
Q2
$306K Buy
5,672
+720
+15% +$38.7K 0.12% 143
2023
Q1
$269K Buy
+4,952
New +$241K 0.11% 143

Other funds holding SNY

Lantz Financial's SNY Position: Q2 2026 in Review

Lantz Financial increased its Sanofi (SNY) stake by 8.2% in Q2 2026, buying an estimated $48.6K and bringing the position to 14,278 shares worth $609K. The position accounts for 0.11% of the portfolio, ranked #160.

Lantz Financial first reported a position in SNY in Q1 2023 and has held it in 14 quarters since. The position peaked at $635K in Q1 2026. 109 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Lantz Financial held 14,278 shares of Sanofi worth $609K as of Q2 2026.
  • Lantz Financial bought 1,088 Sanofi shares in Q2 2026, an estimated $48.6K.
  • Sanofi made up 0.11% of Lantz Financial's portfolio in Q2 2026, its #160 holding.
  • Lantz Financial first reported a position in Sanofi in Q1 2023 and has held it in 14 quarters since.
  • Lantz Financial's Sanofi position peaked at $635K in Q1 2026.
  • 109 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Lantz Financial's 13F filing for Q2 2026, filed 9 Jul 2026.